Literature DB >> 19830686

Mining mammalian genomes for folding competent proteins using Tat-dependent genetic selection in Escherichia coli.

Hyung-Kwon Lim1, Thomas J Mansell, Stephen W Linderman, Adam C Fisher, Michael R Dyson, Matthew P DeLisa.   

Abstract

Recombinant expression of eukaryotic proteins in Escherichia coli is often limited by poor folding and solubility. To address this problem, we employed a recently developed genetic selection for protein folding and solubility based on the bacterial twin-arginine translocation (Tat) pathway to rapidly identify properly folded recombinant proteins or soluble protein domains of mammalian origin. The coding sequences for 29 different mammalian polypeptides were cloned as sandwich fusions between an N-terminal Tat export signal and a C-terminal selectable marker, namely beta-lactamase. Hence, expression of the selectable marker and survival on selective media was linked to Tat export of the target mammalian protein. Since the folding quality control feature of the Tat pathway prevents export of misfolded proteins, only correctly folded fusion proteins reached the periplasm and conferred cell survival. In general, the ability to confer growth was found to relate closely to the solubility profile and molecular weight of the protein, although other features such as number of contiguous hydrophobic amino acids and cysteine content may also be important. These results highlight the capacity of Tat selection to reveal the folding potential of mammalian proteins and protein domains without the need for structural or functional information about the target protein.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19830686      PMCID: PMC2821272          DOI: 10.1002/pro.262

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  53 in total

1.  Translocation of jellyfish green fluorescent protein via the Tat system of Escherichia coli and change of its periplasmic localization in response to osmotic up-shock.

Authors:  C L Santini; A Bernadac; M Zhang; A Chanal; B Ize; C Blanco; L F Wu
Journal:  J Biol Chem       Date:  2000-11-30       Impact factor: 5.157

2.  GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes.

Authors:  A J Walhout; G F Temple; M A Brasch; J L Hartley; M A Lorson; S van den Heuvel; M Vidal
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

3.  Transport of cytochrome c derivatives by the bacterial Tat protein translocation system.

Authors:  C Sanders; N Wethkamp; H Lill
Journal:  Mol Microbiol       Date:  2001-07       Impact factor: 3.501

4.  Cell-free translation reconstituted with purified components.

Authors:  Y Shimizu; A Inoue; Y Tomari; T Suzuki; T Yokogawa; K Nishikawa; T Ueda
Journal:  Nat Biotechnol       Date:  2001-08       Impact factor: 54.908

5.  Parallel cloning, expression, purification and crystallization of human proteins for structural genomics.

Authors:  Hai-tao Ding; Hui Ren; Qiang Chen; Gang Fang; Lan-fen Li; Rui Li; Zhuo Wang; Xiao-yu Jia; Yu-he Liang; Mei-hao Hu; Yi Li; Jing-chu Luo; Xiao-cheng Gu; Xiao-dong Su; Ming Luo; Shan-yun Lu
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-11-23

6.  Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein.

Authors:  C Wang; A F Castro; D M Wilkes; G A Altenberg
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

7.  Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm.

Authors:  P H Bessette; F Aslund; J Beckwith; G Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

8.  Rapid screening for improved solubility of small human proteins produced as fusion proteins in Escherichia coli.

Authors:  Martin Hammarström; Niklas Hellgren; Susanne van Den Berg; Helena Berglund; Torleif Härd
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

9.  Protein solubility and folding monitored in vivo by structural complementation of a genetic marker protein.

Authors:  W C Wigley; R D Stidham; N M Smith; J F Hunt; P J Thomas
Journal:  Nat Biotechnol       Date:  2001-02       Impact factor: 54.908

10.  Visualization of coupled protein folding and binding in bacteria and purification of the heterodimeric complex.

Authors:  Haoyong Wang; Shaorong Chong
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

View more
  5 in total

1.  A rapid protein folding assay for the bacterial periplasm.

Authors:  Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Matthew P DeLisa
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

Review 2.  A microbial sensor for discovering structural probes of protein misfolding and aggregation.

Authors:  Dujduan Waraho-Zhmayev; Lizeta Gkogka; Ta-Yi Yu; Matthew P DeLisa
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

3.  Engineering antibody fitness and function using membrane-anchored display of correctly folded proteins.

Authors:  Amy J Karlsson; Hyung-Kwon Lim; Hansen Xu; Mark A Rocco; Matthew A Bratkowski; Ailong Ke; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2011-12-16       Impact factor: 5.469

4.  A method for multiplex gene synthesis employing error correction based on expression.

Authors:  Timothy H-C Hsiau; David Sukovich; Phillip Elms; Robin N Prince; Tobias Strittmatter; Tobias Stritmatter; Paul Ruan; Bo Curry; Paige Anderson; Jeff Sampson; J Christopher Anderson
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

5.  Directed evolution of human heavy chain variable domain (VH) using in vivo protein fitness filter.

Authors:  Dong-Sik Kim; Hyung-Nam Song; Hyo Jung Nam; Sung-Geun Kim; Young-Seoub Park; Jae-Chan Park; Eui-Jeon Woo; Hyung-Kwon Lim
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.